disease (Soulier et al., 1995) . As observed in other herpesviruses, several HHV-8 open reading frames display striking identity to known cellular genes encoding proteins involved in nucleotide metabolism (e.g. dihydrofolate reductase, ribonucleotide reductase, thymidine kinase, thymidine synthetase and dUTPase). It is believed that these enzymes are expressed during the lytic infection phase, but there are only limited data concerning the function and characterization of these viral enzymes (Neipel et al., 1997 ; Sarid et al., 1998) .
dUTPase (EC 3.6.1.23 ) is an essential enzyme in nucleotide metabolism, hydrolysing dUTP to dUMP. This reaction is important for two reasons : (i) it provides dUMP, the direct precursor for de novo dTTP synthesis and (ii) it reduces the intracellular ratio of dUTP\dTTP and prevents the mutagenic or lethal misincorporation of uracil in DNA (Shlomai & Kornberg, 1978) . The importance of the enzyme for cell viability is well documented in E. coli and S. cerevisiae and the dUTPase has been shown to be required for efficient replication in several virus systems (el Hajj et al., 1988 ; Gadsden et al., 1993 ; Jo$ ns et al., 1997 ; Lerner et al., 1995 ; Lichtenstein et al., 1995 ; Pyles et al., 1992 ; Ross et al., 1997 ; Steagall et al., 1995) . We characterized ORF BLLF3 of EBV as an active dUTPase (Sommer et al., 1996) and were interested to see if HHV-8 ORF54, which displays sequence similarity to BLLF3, also encodes a functional enzyme.
The coding sequence for HHV-8 ORF54 (nucleotides 77966-78922 ; Neipel et al., 1997) was obtained by PCR amplification of DNA from BCBL-1 cells using primers HHV8DUT-5h (5h CGCGGATCCCATATGAACAACCGC-CGAGGC 3h) and HHV8DUT-3h (5h CGCCCTAGGCTA-AAACCCAGACGACCCCAG 3h). Primer HHV8DUT-5h contains the recognition sequences for the restriction enzymes BamHI and NdeI. The PCR product was cloned into the pMOSBlue T-vector (Amersham), resulting in the construct pMOS-ORF54. For recombinant expression of the protein the 0001-6094 # 1999 SGM BDAF E. Kremmer and others E. Kremmer and others (a) (b) (c) Fig. 1 . Expression of the HHV-8 dUTPase and production of MAbs against the enzyme. (a) The complete ORF54 of HHV-8 was expressed in E. coli as a trpE-fusion protein and analysed in a Western blot with trpE-specific MAbs at the indicated timepoints of induction (lanes designated ' pATH-ORF54 '). Non-fusion protein was used as control (lanes designated ' pATH '). The positions of trpE, the trpE-ORF54 fusion protein and the molecular mass marker proteins (i10 HHV-8 ORF54-specific BamHI fragment from pMOS-ORF54 was inserted into either vector pATH11 (Koerner et al., 1991) or pGEX4T1 (Pharmacia) and expressed as a trpE-or GSTfusion protein, respectively, in E. coli strain BL21\DE3 (Studier et al., 1990) . Western blot analysis using a trpE-or GST-specific monoclonal antibody (MAb ; Connex) showed expression of both the trpE-ORF54 fusion protein with the expected molecular mass of about 72 kDa (Fig. 1 a) and the GST-ORF54 fusion protein with the expected molecular mass of about 60 kDa (Fig. 1 b) . MAbs were induced in Lou\c rats using the gel-purified trpE-ORF54 fusion protein as previously described (Kremmer et al., 1995) . Clone 5E6 (IgG2a) clearly detected the HHV-8 ORF54 as either a trpE-or a GST-fusion protein expressed in E. coli, but not the trpE-or the GST-non-fusion proteins (data not shown). To further characterize the antibodies, several B cell lines were tested for the expression of the HHV-8 ORF54 protein. First, the lytic infection cycle was induced by treatment of B cells with TPA at a final concentration of 20 ng\ml (Boos et al., 1987 ; Renne et al., 1996 b ; zur Hausen et al., 1978) , using BL41 (Lenoir et al., 1985) as a negative control. As demonstrated in Fig. 1 (c) , 5E6 detected the expression of HHV-8 ORF54 with the expected molecular mass of about 35 kDa in HHV-8-positive BCBL-1 cells , and no signal was obtained in the EBV-negative B cell line BL41 or in the EBV-positive cell line B95.8 (Miller & Lipman, 1973) . While uninduced BCBL-1 cells showed only very weak expression of the enzyme, the amount of protein increased significantly after induction of the lytic replication cycle with TPA. Furthermore, treatment of the cells with phosphonoacetic acid (PAA ; 400 µg\ml) did not change the level of dUTPase as compared to untreated cells, while pretreatment with PAA 24 h prior to induction resulted only in a slight reduction of the levels of dUTPase when compared to the TPA-stimulated cells. These results indicated that HHV-8 ORF54 is expressed early during the lytic phase of infection.
BDAG KSHV/HHV-8 dUTPase KSHV/HHV-8 dUTPase Fig. 2 . Detection of the dUTPase activity of HHV-8 ORF54. Bacterial extracts were prepared from E. coli strain BL21/DE3 transformed with the parental vector pGST, the vector pGST-DUT1, which encodes the human dUTPase fused to the GST protein, and with pGST-ORF54 encoding the GST-HHV-8 dUTPase. The extracts were incubated with dUTP for the indicated times and the nucleotide phosphates generated were separated by thin layer chromatography as described in the text. As a reference, dUMP, dUTP and a mix of dUMP/dUTP were spotted separately as indicated on top of the three leftmost lanes. The positions of dUMP, dUDP and dUTP are shown.
Since HHV-8 ORF54 displays sequence similarity to dUTPases, we then asked whether the gene encodes an active enzyme. For this purpose, 50 ml samples of bacterial cultures from cells expressing GST-ORF54 were harvested 4 h after induction of protein expression by centrifugation at 6000 r.p.m. for 10 min. Bacterial pellets were resuspended in 1 ml buffer (20 mM HEPES, 100 mM NaCl, 5 mM MgCl # , 0n01 % NP-40, pH 7n2) and cells were lysed by a 15 s sonication.
To determine dUTPase activity, 15 µl of E. coli cell extract (1n5 µg\µl protein concentration) was added to 10 µl of a 10 mM dUTP solution and incubated at 37 mC for the indicated time as shown in Fig. 2 . The reaction was stopped by adding 7 µl 0n2 M EDTA and 16 µl aliquots were spotted onto polyethylenimine cellulose (with fluorescent indicator ; Sigma). Separation was carried out by ascending chromatography in a buffer consisting of 0n25 M KH # PO % , pH 3n5. The nucleotides were visualized with UV light at 260 nm. Extracts from E. coli harbouring the parental plasmid (pGEX4T1) or the human dUTPase (pGST-DUT1 ; Climie et al., 1994) served as controls. While bacterial extracts from cells expressing the GST protein showed a low background level of dUTP hydrolysis due to endogenous E. coli dUTPase activity, extracts from E. coli expressing either GST-ORF54 or GST-DUT1 clearly demonstrated a nearly complete conversion of dUTP to dUMP after 30 min of incubation. It should be noted that there was no increase in the amount of dUDP after 60 min of incubation, indicating that there is a specific hydrolysis of dUTP to dUMP. The dUTPase activity of HHV-8 ORF54 was further confirmed using the method described by . Again, a specific hydrolysis of dUTP was only observed using extracts from cells harbouring GST-DUT1 or GST-ORF54, while control extracts displayed only background levels of activity (data not shown).
MAb 5E6 was further used for in situ staining of the HHV-8 dUTPase in HHV-8-positive or -negative cell lines as well as in tissue sections of KS. Cytospin preparations from BCBL-1 cells were produced using a cytocentrifuge, air-dried overnight, and fixed in acetone for 20 min. TPA-treated and formaldehyde-fixed BCBL-1 and B95.8 cells were also embedded in paraffin and sectioned using standard histopathological techniques. Paraffin sections (3 µm) from six cases of histologically confirmed KS (five skin biopsies and one lymph node biopsy) were also available. The cases analysed were derived either from human immunodeficiency virus (HIV)-negative Russian patients or from HIV-positive patients from Germany. All patients had significantly elevated levels of serum antibodies to HHV-8, as demonstrated by immunofluorescence (data not shown). First, the presence or absence of HHV-8 transcripts in the cell lines and tissues used was assayed by in situ hybridization as described previously (Niedobitek et al., 1991) . $&S-labelled antisense and sense RNA probes were generated by in vitro transcription using plasmid pBST07, which contains the T0.7 cDNA of HHV-8 (Stu$ rzl et al., 1997) . In situ hybridization using the T0.7-specific antisense probe revealed expression of this viral RNA in a large proportion of BCBL-1 cells (Fig. 3 a) . No labelling was seen using the corresponding sense probe (Fig. 3 b) . In four of six KS biopsies expression of the T0.7 RNA was observed in the spindle cells (Fig. 3 c, d ), confirming the presence of HHV-8 in these cases.
Subsequently, the expression of HHV-8 dUTPase was examined in cell lines and KS tissues using MAb 5E6. For control purposes, cell lines and tissue sections were also stained with a MAb specific for the human dUTPase (3E6) and with MAb MIB-1, which detects the proliferation-associated Ki-67 antigen (Cattoretti et al., 1992 ; Gerdes et al., 1983) . Cytospin preparations were stained using the alkaline phosphatase anti-alkaline phosphatase (APAAP) method (Cordell et al., 1984) . Paraffin sections were dewaxed, rehydrated and subjected to microwave treatment as described previously (Niedobitek et al., 1997) . Following incubation with the primary antibody, the sections were incubated with a biotinylated rabbit anti-rat IgG (for 5E6 and 3E6) or biotinylated rabbit anti-mouse IgG (for MIB-1). Subsequently, the sections were exposed to a streptavidin-biotinylated alkaline phosphatase complex (Dako) and developed using Fast red (Sigma) as chromogen.
HHV-8 dUTPase was detected in a small proportion of acetone-fixed BCBL-1 cells (Fig. 3 e) . The enzyme was also observed in formalin-fixed, paraffin-embedded BCBL-1 cells (Fig. 3 f ) BDAI KSHV/HHV-8 dUTPase KSHV/HHV-8 dUTPase expressed the Ki-67 antigen, indicating that these cells were proliferating. A similar proportion of cells expressed the human dUTPase, as detected using MAb 3E6 (Fig. 3 h) . In addition, human dUTPase was regularly detected in a proportion of suprabasal epithelial cells of the epidermis in the five skin biopsies. In the lymph node, expression of the human dUTPase was also seen in germinal centre cells and some extrafollicular lymphocytes. Using MAb 5E6, expression of HHV-8 dUTPase was completely absent in five cases. In the sixth case, a single labelled cell was detected, the morphology of which was consistent with a tumour cell (Fig. 3 g) . This case was also positive for HHV-8, as detected by in situ hybridization. This is consistent with the observation that the vast majority of cells in KS lesions is latently infected with only 1-5 % of spindle cells in AIDS KS patients supporting the lytic cycle (Staskus et al., 1997) . The absence of lytic cycle proteins in the KS tissue is reminiscent of the situation observed for the EBV-positive nasopharyngeal carcinoma. In patients with this tumour, which is always EBV-positive, high titres of antibodies to lytic cycle proteins are detectable, while the tumour itself shows only very limited lytic gene expression. However, MAb 5E6, generated against the viral enzyme, might be useful in further studies concerning lytic virus replication of HHV-8. Regarding this aspect, we have shown that the EBV-encoded dUTPase is at least as good a marker as the viral BZLF-1 protein, which is the usual marker for lytic EBV-replication (Nicholls et al., 1998) .
Viral dUTPases have been suggested to be potential targets for drug therapy, since they influence the pathogenicity and the cell tropism of a virus by enabling virus replication in otherwise non-dividing, resting cells (el Hajj et al., 1988 ; Gadsden et al., 1993 ; Jo$ ns et al., 1997 ; Lerner et al., 1995 ; Lichtenstein et al., 1995 ; Pyles et al., 1992 ; Ross et al., 1997 ; Steagall et al., 1995) . Furthermore, most dUTPase active enzymes are homo-trimeric complexes (e.g. the human or the E. coli enzyme), where three active sides are built by five highly conserved motifs from each monomeric chain (Larsson et al., 1996 b ; Mol et al., 1996) . In contrast, the herpesviral enzymes appear to be monomeric (Caradonna & Adamkiewicz, 1984 ; McGeoch, 1990) . Additionally, there are differences in the substrate specificity and the kinetics of dUTPases from viruses and their host enzymes, which define possibilities for the design of specific and selective drugs (Bjo$ rnberg & Nyman, 1996 ; Nord et al., 1997 ; Williams, 1988) . The cloning and functional expression of the HHV-8-encoded dUTPase will allow the production of large quantities of enzyme as a first step towards the rational design of selective and specific antiviral drugs with potential medical applications.
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